Get the Stockscreener App
5.99
5.07%
-0.32
Portage Biotech Inc Stock (PRTG) Forecast
The Portage Biotech Inc (PRTG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.24, representing a +137.72% increase from the current price of $5.99. The highest analyst price target is $14.32, and the lowest is $14.16.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRTG Price Target
Average 11.29
(+88.55% Upside)
Is Portage Biotech Inc (PRTG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.91 | Neutral |
| STOCH(9,6) | 18.77 | Buy |
| STOCHRSI(14) | 17.82 | Buy |
| MACD(12,26) | -0.3602 | Sell |
| ADX(14) | 29.55 | Sell |
| William %R | -98.78 | Buy |
| CCI(14) | -255.67 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.5695
Sell
|
7.2933
Sell
|
| MA20 |
7.8153
Sell
|
7.6809
Sell
|
| MA50 |
8.0766
Sell
|
7.6045
Sell
|
| MA100 |
6.4147
Sell
|
6.9264
Sell
|
| MA200 |
5.8097
Buy
|
6.4935
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, PRTG could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on PRTG, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.91 indicates that PRTG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.77 indicates that PRTG is oversold. This indicates that PRTG price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.82 indicates that PRTG is oversold. This suggests that PRTG price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.55 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -255.67 indicates that PRTG is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term PRTG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Portage Biotech Inc financial reports and earnings history, Portage Biotech Inc (PRTG) stock could reach $22.69 by 2030, $99.60 by 2040 and $206.10 by 2050. See the projected annual prices until 2050 of the Portage Biotech Inc stock below:
- Portage Biotech Inc (PRTG) is expected to reach an average price of $3.6264 in 2035, with a high prediction of $5.5824 and a low estimate of $3.7297. This indicates an $-39.46% rise from the last recorded price of $5.99.
- Portage Biotech Inc (PRTG) stock is projected to chart a bullish course in 2040, with an average price target of $98.72, representing an $1,548% surge from its current level. The forecast ranges from a conservative $99.16 to a sky-high $99.60.
- Our analysts predict Portage Biotech Inc (PRTG) to jump 752.76% by 2045, soaring from $51.19 to an average price of $51.08, potentially reaching $53.65. While $51.19 is the low estimate, the potential upside is significant.
- Portage Biotech Inc (PRTG) stock is expected to climb by 2050, reaching an average of $206.83, a $3,353% jump from its current level. However, a wide range of estimates exists, with high and low targets of $206.10 and $197.86, respectively, highlighting the market's uncertainty.
Portage Biotech Inc Stock (PRTG) Year by Year Forecast
Portage Biotech Inc Stock (PRTG) Price Forecast for 2025
Portage Biotech Inc Stock (PRTG) is expected to reach an average price of $9.0988 in 2025, with a high prediction of $14.32 and a low estimate of $3.8783. This indicates an +51.90% rise from the last recorded price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $14.36 | $14.16 | $14.32 | +139.72% |
| August, 2025 | $14.88 | $15.02 | $14.17 | +148.44% |
| September, 2025 | $9.9141 | $12.64 | $14.02 | +65.51% |
| October, 2025 | $12.22 | $9.9872 | $10.82 | +104.00% |
| November, 2025 | $9.2421 | $10.08 | $11.27 | +54.29% |
| December, 2025 | $10.01 | $8.7738 | $8.5877 | +67.07% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2026
The predicted value for Portage Biotech Inc (PRTG) in 2026 is set at an average of $7.3836. Estimates vary from a peak of $9.3891 to a trough of $5.3782, indicating an +23.27% surge from the present price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.4902 | $8.7302 | $9.005 | +41.74% |
| February, 2026 | $9.4826 | $9.4633 | $9.3891 | +58.31% |
| March, 2026 | $8.8451 | $9.185 | $8.6951 | +47.66% |
| April, 2026 | $8.7006 | $8.7958 | $8.5475 | +45.25% |
| May, 2026 | $9.2631 | $8.5837 | $8.7731 | +54.64% |
| June, 2026 | $8.3255 | $8.2693 | $7.9462 | +38.99% |
| July, 2026 | $8.4311 | $8.0518 | $7.9261 | +40.75% |
| August, 2026 | $8.4836 | $8.4773 | $8.0942 | +41.63% |
| September, 2026 | $7.7591 | $8.0691 | $8.3553 | +29.53% |
| October, 2026 | $7.0316 | $7.2015 | $7.2622 | +17.39% |
| November, 2026 | $5.924 | $6.094 | $6.7747 | -1.10% |
| December, 2026 | $5.1496 | $5.3782 | $5.4065 | -14.03% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Portage Biotech Inc (PRTG) is $15.19, with a high forecast of $30.21 and a low forecast of $0.1652. This indicates an +153.52% increase from the last price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.852 | $5.0817 | $5.0389 | -19.00% |
| February, 2027 | $4.7645 | $5.0544 | $4.9814 | -20.46% |
| March, 2027 | $4.1801 | $4.1901 | $4.4907 | -30.22% |
| April, 2027 | $3.7125 | $3.8025 | $3.9963 | -38.02% |
| May, 2027 | $3.765 | $3.5618 | $3.5087 | -37.15% |
| June, 2027 | $3.2605 | $3.2574 | $3.4181 | -45.57% |
| July, 2027 | $2.643 | $2.5499 | $2.8686 | -55.88% |
| August, 2027 | $2.1954 | $2.2654 | $2.1761 | -63.35% |
| September, 2027 | $1.641 | $1.641 | $2.0385 | -72.60% |
| October, 2027 | $1.0634 | $1.1134 | $1.4542 | -82.25% |
| November, 2027 | $0.6249 | $0.696 | $0.7566 | -89.57% |
| December, 2027 | $30.42 | $0.1652 | $30.21 | +407.78% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2028
In 2028, Portage Biotech Inc (PRTG) is projected to reach an average price of $31.54, with a high projection of $39.83 and a low estimate of $23.26. This indicates an +426.62% rise from the last price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $33.20 | $31.81 | $31.95 | +454.28% |
| February, 2028 | $32.04 | $33.54 | $31.38 | +434.83% |
| March, 2028 | $28.99 | $30.00 | $31.02 | +383.93% |
| April, 2028 | $36.57 | $23.26 | $31.83 | +510.55% |
| May, 2028 | $40.72 | $36.48 | $38.57 | +579.85% |
| June, 2028 | $33.06 | $34.96 | $39.83 | +451.89% |
| July, 2028 | $33.89 | $34.06 | $32.42 | +465.83% |
| August, 2028 | $30.33 | $32.19 | $31.02 | +406.41% |
| September, 2028 | $28.46 | $28.97 | $29.70 | +375.11% |
| October, 2028 | $35.77 | $30.79 | $33.78 | +497.23% |
| November, 2028 | $36.11 | $35.34 | $35.05 | +502.76% |
| December, 2028 | $37.17 | $36.85 | $36.54 | +520.53% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2029
The 2029 price forecast for Portage Biotech Inc Stock (PRTG) is $29.80 on average, with a high prediction of $36.61 and a low estimate of $23.00. This represents an +397.53% increase from the previous price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $36.23 | $36.61 | $36.61 | +504.86% |
| February, 2029 | $35.99 | $35.75 | $35.58 | +500.77% |
| March, 2029 | $35.12 | $35.89 | $35.41 | +486.33% |
| April, 2029 | $33.98 | $34.98 | $34.59 | +467.21% |
| May, 2029 | $27.51 | $29.57 | $31.21 | +359.21% |
| June, 2029 | $30.08 | $30.21 | $29.85 | +402.20% |
| July, 2029 | $25.72 | $26.69 | $28.34 | +329.33% |
| August, 2029 | $26.46 | $26.66 | $26.26 | +341.70% |
| September, 2029 | $26.02 | $25.48 | $25.02 | +334.44% |
| October, 2029 | $24.48 | $24.96 | $25.64 | +308.75% |
| November, 2029 | $24.27 | $24.04 | $24.11 | +305.16% |
| December, 2029 | $22.94 | $23.00 | $23.30 | +283.03% |
Portage Biotech Inc Stock (PRTG) Price Forecast for 2030
Portage Biotech Inc Stock (PRTG) is expected to reach an average price of $15.96 in 2030, with a high forecast of $22.69 and a low forecast of $9.2275. This signifies an +166.39% surge from the last price of $5.99.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $21.38 | $21.85 | $22.69 | +256.91% |
| February, 2030 | $20.89 | $20.96 | $20.66 | +248.74% |
| March, 2030 | $20.33 | $20.55 | $20.34 | +239.48% |
| April, 2030 | $20.14 | $20.29 | $19.78 | +236.23% |
| May, 2030 | $17.81 | $18.15 | $19.19 | +197.34% |
| June, 2030 | $16.42 | $17.12 | $17.22 | +174.05% |
| July, 2030 | $14.79 | $14.89 | $15.94 | +146.86% |
| August, 2030 | $13.66 | $13.79 | $14.31 | +128.07% |
| September, 2030 | $13.04 | $13.08 | $13.28 | +117.72% |
| October, 2030 | $11.16 | $11.33 | $12.55 | +86.27% |
| November, 2030 | $10.31 | $10.76 | $10.47 | +72.16% |
| December, 2030 | $9.1675 | $9.2275 | $9.2088 | +53.05% |
1.91%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):